Immune-related adverse events associated with immune checkpoint inhibitors for advanced gastric and gastroesophageal junction cancer: A meta-analysis

BACKGROUND: Immune checkpoint inhibitors (ICIs) have shown promising efficacy in treatment and clinical management of advanced gastric and gastroesophageal junction cancer. However, the inhibitors also cause immune-related adverse events (irAEs). The current systematic review and meta-analysis study...

Descripción completa

Detalles Bibliográficos
Autores principales: Pei, Wen-Guang, Chen, Wen-Zheng, Wu, Yu-Kang, Tan, Sheng-Xing, Jie, Zhi-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994050/
https://www.ncbi.nlm.nih.gov/pubmed/36908315
http://dx.doi.org/10.4251/wjgo.v15.i2.352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994050/
https://www.ncbi.nlm.nih.gov/pubmed/36908315
http://dx.doi.org/10.4251/wjgo.v15.i2.352

Ejemplares similares